CSX CORPORATION (CSX): what the price requires
At today's price, CSX CORPORATION (CSX) is priced for +12.1% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-17 · Source: https://boothcheck.com/report/CSX
Headline
| Field | Value |
|---|---|
| Ticker | CSX |
| Company | CSX CORPORATION |
| Sector / Industry | Industrials / Railroads |
| Current price | $49.75/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 28.4% |
| Operating margin today | 33.2% |
| Margin compression implied | -4.8pp |
| Implied growth | 12.1% |
| Multiple paid | 23x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 8.1% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.6pp.
Reconcile: at the x-ray's 9.3% required return this reads ~20.6%/yr; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.53σ |
| cohort percentile (of 225 peers) | 53 |
| sustained it ~5 years at this level | 50% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 2.81x | 5 | expensive |
| Earnings | 2.82x | 3 | expensive |
| Relative | 1.45x | 3 | expensive |
| Growth | 1.32x | 3 | expensive |
Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $3.65 | 13.63x | yes | FCF base $1.9B, growth -1% (input: historical growth), terminal g 0.5%, WACC 7.8%, 5yr projection |
| DCF Exit Multiple | Growth | $46.51 | 1.07x | yes | Exit EV/EBITDA: 15.5x / 17.5x / 19.5x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $36.00 | 1.38x | yes | P/E 23.11x (blended: static sector reference 20x + trailing (TTM) 30x), scenarios: 19.5x / 23.1x / 26.7x (bear / base = reference held flat / bull), EV/EBITDA 13x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $17.71 | 2.81x | yes | BV/sh $7.29, ROE (TTM) 22.5%, ke 9.3% |
| Two-Stage Excess Return | Asset | $27.48 | 1.81x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $37.55 | 1.32x | yes | Rev $14.2B, growth -1% (input: historical growth; tapered), Terminal P/S: 5.5x / 6.5x / 7.6x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $21.99 | 2.26x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $5.45B × (1−24%) / WACC 7.8% → EPV (no growth) |
| Residual Income | Asset | $25.61 | 1.94x | yes | BV $7.29 + 5yr PV of (ROE (TTM) 22.5% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $16.35 | 3.04x | yes | √(22.5 × EPS $1.63 × BVPS $7.29) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $34.32 | 1.45x | yes | EBITDA $6.40B × sector EV/EBITDA 13.0x |
| FCF Yield | Earnings | $0.67 | 74.25x | yes | FCF $1904.0M / Kₑ 9.3% — zero-growth perpetuity (excluded from median) |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $11.16 | 4.46x | yes | EPS $1.63 × (8.5 + 2×-0.2%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $2.70 | 18.42x | yes | BV $7.29 × (ROIC 2.9% / WACC 7.8%) |
| P/Sales Sector | Relative | $15.20 | 3.27x | yes | Revenue $14.15B × sector P/S 2.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $17.62 | 2.82x | yes | EPS $1.63 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $18.7b |
| Net debt / NOPAT (after-tax) | 5.29x |
| Net debt / operating income (pre-tax) | 4.01x |
| Interest coverage | 5.5x |
| Share count CAGR (buyback) | -4.0% |
| Burning cash | no |
Bullet Takeaways
At $47.61 (as of June 27, 2026) the price pays about 21x company-wide operating income, which implies roughly 10% annual operating-profit growth for five years. That rate is within what CSX has delivered; the stretch is duration, not pace.
The valuation X-ray is uniformly rich: no model family reaches the price. Asset, earnings-power, peer-multiple, and even forward-growth methods all land below $47.61, so the price embeds something the standard frames cannot, most plausibly a consolidation premium.
Q1 2026 was clean: operating income up about 20% on 3% volume growth and a 6% expense cut, with EPS of $0.43 beating estimates. Net debt of roughly $18.7 billion runs near 4x operating income at 5.6x interest coverage, and the share count has been shrinking about 4% a year.
Bull Case
The balance sheet tells you how management thinks about its own business. CSX carries about $18.7 billion of net debt against $4.7 billion of trailing operating income, roughly 4x, with interest covered about 5.6 times. That is leverage chosen on purpose, not forced: a railroad with a 33% operating margin and decades of stable cash flow can carry debt cheaply, and CSX has used that capacity to shrink its share count by about 4% a year while still investing in the network. Management borrowing against the future and buying back stock at this level is a statement that it views the equity as worth more than the market pays. The asset base behind that debt is irreplaceable. Through a network of roughly 30 terminals, the intermodal business serves all major markets east of the Mississippi, offering a cost and environmental advantage over long-haul trucking (FY2025 10-K, accession 0000277948-26-000006). You cannot lay a competing rail network across the eastern United States.
The operating results show the model working. Q1 2026 operating income rose about 20%, driven by 3% volume growth paired with a 6% reduction in operating expenses, with EPS of $0.43 beating the $0.39 consensus. Intermodal volume grew 6%, the segment where rail takes share from trucks, and merchandise pricing and domestic coal added to the top line. A railroad that can lift operating income 20% on 3% volume is demonstrating the operating leverage that makes the business attractive: most of each incremental dollar of revenue falls to profit once the network is in place.
The strategic backdrop adds an option the price reflects. The industry has consolidated to four railroads handling nearly 90% of freight, and Union Pacific's $85 billion agreement to acquire Norfolk Southern has put the remaining players in motion. CSX is widely discussed as a potential partner for BNSF or Canadian Pacific Kansas City, and activist Ancora is pressing the company to pursue scale. Management has said it is focused on executing the base business so it can enter any consolidation scenario from a position of strength. That is the bull case in one line: an irreplaceable eastern network, real operating leverage, disciplined capital return, and a live consolidation option, with the priced-in roughly 10% growth assumption within what the company has shown.
Bear Case
The variable with the most leverage on this thesis is regulation and the macro freight cycle, and the current price does not reflect how much rides on the merger backdrop. The entire industry sits in front of the Surface Transportation Board, and the UP-NS deal has already hit regulatory roadblocks, with BNSF and CN filing to force more disclosure, a supplemental-information deadline in July 2026, and a final decision not expected until late 2026 or 2027. CSX's own CEO opposed the merger at the May 2026 shareholder meeting. If UP-NS clears, CSX faces a transcontinental competitor and is pushed toward a deal of its own from a weaker hand; if a CSX merger is blocked or never materializes, the consolidation premium embedded in the price evaporates. Either way, the stock's near-term path is hostage to a regulatory process measured in years, not quarters.
The demand side is cyclical and commodity-exposed. The filing is explicit that if the company experiences significant declines in demand for its transportation services with respect to one or more commodities, or continues to feel the impacts of inflation, it may experience reduced revenue (FY2025 10-K, accession 0000277948-26-000006). Coal remains a swing factor, with export coal revenue already declining in Q1 2026, and the company competes by commodity and geography against other railroads and motor carriers (FY2025 10-K, accession 0000277948-26-000006). A freight recession compresses both volumes and the operating leverage that the bull case celebrates, in the same direction at the same time.
The valuation leaves no margin for any of that. The X-ray is unusually emphatic: no model family reaches $47.61. The relative read lands near $33, the earnings-power method near $18, the asset methods in the high teens to low twenties, and even the forward-growth methods top out near $32 to $40. The price is a bet beyond what any standard frame supports, and the most natural explanation is a takeover or consolidation premium that may not pay off. Net debt near $18.7 billion is comfortable in good times but adds fragility into a downturn, and the price already requires roughly 10% operating growth sustained for five years. If the merger optionality fades and the freight cycle softens, the methods clustering in the $18 to $34 range are the honest read, and there is meaningful downside to the price.
Valuation
Invert the price first. At $47.61 the market pays about 21x company-wide operating income, which solves to roughly 10% annual operating-profit growth over five years, computed at an 8.1% cost of capital with 4% terminal growth. That implied rate is within what CSX has recently delivered, so the priced-in assumption reads as within range, with the stretch being how long the pace persists rather than the pace itself. The read is rate-sensitive: each one-point move in the cost of capital shifts the required growth by about 7.4 points. To get there, the price also requires the business to hold roughly a 27% operating margin against the 33% it runs today, so the math leans on durable, slightly-fading profitability.
The valuation X-ray is the striking part: no family reaches the price. The relative methods land near $33 to $34, the asset methods near $16 to $23, the earnings-power methods near $9 to $18, and even the forward-growth methods top out near $32 to $40, with the DCF exit-multiple read at about $40 the closest any method gets. When every standard frame, including growth, sits below the quote, the price is carrying something the methods cannot price. In CSX's case that something is most plausibly the consolidation premium: a market handicapping the odds and value of a merger in a four-railroad industry.
The synthesis is that CSX is priced for both durable compounding and a strategic event. The within-range growth solve says the operating business can roughly justify a full multiple if it sustains its recent pace, but the X-ray says the current price sits above where the operating fundamentals alone land. The gap is option value on consolidation. If a deal happens at a premium, today's price looks cheap; if it does not, the methods clustering between $18 and $40 are the relevant anchors. The peers, Norfolk Southern, Canadian Pacific Kansas City, Canadian National, and Union Pacific, trade on the same dynamic, which is why this is a sector-wide repricing as much as a CSX-specific one.
Catalysts
The dominant catalyst is industry consolidation. Union Pacific and Norfolk Southern signed an $85 billion merger agreement on July 28, 2025, and that deal is now grinding through the Surface Transportation Board with BNSF and CN seeking more documents, a supplemental-information deadline in late July 2026, and a final ruling expected in late 2026 or 2027. CSX is the most-discussed next domino: analysts speculate it could be a target of BNSF, activist Ancora is publicly pushing CSX to engage with BNSF or Canadian Pacific Kansas City, and CSX management has framed its strategy as executing the base business to enter any consolidation scenario from a position of strength. Every regulatory milestone in the UP-NS process is a CSX catalyst by extension, in either direction. Note that Berkshire's Warren Buffett has denied reports of BNSF-CSX contact, so the takeover thesis remains speculative.
On fundamentals, Q1 2026 results reported in April delivered operating income up about 20% on 3% volume growth and a 6% expense reduction, with EPS of $0.43 beating the $0.39 consensus and revenue of $3.48 billion up 2% but just shy of estimates. Intermodal volume grew 6%, the clearest near-term volume driver, while export coal revenue fell. The next earnings report and any update on intermodal share gains and coal pricing are the operational events to watch. Capital return through continued buybacks, with the share count already shrinking about 4% a year, is a steady support. The combination of a live merger cycle and steady operating execution makes this a name where the strategic news flow will likely matter more than any single quarter.
Sources: CSX Q1 2026 results press release (CSX.com), CSX Q1 2026 8-K (SEC), Union Pacific and Norfolk Southern, CSX won't rule out M&A (Sourcing Journal), Proposed UP-NS merger (Wikipedia).
Peer Cohorts (Per Segment, With Filing Citations)
Rail (reported)
- NSC (NORFOLK SOUTHERN CORP)
- (no filing in the citation store)
- CP (CANADIAN PACIFIC KANSAS CITY LTD/CN)
- (no filing in the citation store)
- UNP (UNION PACIFIC CORP)
- (no filing in the citation store)
- CNI (CANADIAN NATIONAL RAILWAY CO)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.